How to buy Island Pharmaceuticals (ILA) shares
Learn how to easily invest in Island Pharmaceuticals shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Island Pharmaceuticals Limited is a biotechnology business based in Australia. Island Pharmaceuticals shares (ILA) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Island Pharmaceuticals has a market cap (total outstanding shares value) of $25.1 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Island Pharmaceuticals
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Island Pharmaceuticals. Find the share by name or ticker symbol: ILA. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Island Pharmaceuticals reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Island Pharmaceuticals. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Island Pharmaceuticals stock price (ASX:ILA)Use our graph to track the performance of ILA stocks over time.
Island Pharmaceuticals shares at a glance
|52-week range||$0.2675 - $0.67|
|50-day moving average||$0.3341|
|200-day moving average||$0.3453|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Island Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Island Pharmaceuticals price performance over time
|1 week (2021-10-14)||-1.56%|
|1 month (2021-09-21)||-3.08%|
|3 months (2021-07-21)||6.78%|
|6 months (2021-04-21)||-14.86%|
Island Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||0%|
|Return on equity TTM||-9999999%|
|Market capitalisation||$25.1 million|
TTM: trailing 12 months
Island Pharmaceuticals share dividends
We're not expecting Island Pharmaceuticals to pay a dividend over the next 12 months.
Island Pharmaceuticals overview
Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. Island Pharmaceuticals Limited has a research collaboration agreement with Monash University to screen known molecules against host targets; research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy; research collaboration agreement with Compounds Australia, a drug library containing approximately four and a half thousand molecules that could be searched for drug re-purposing and pipeline development; cooperative research and development agreement with the U.S. Army in preparation for its Phase II clinical study for ISLA-101; supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants; and right to reference National Cancer Institute IND for Isla101. The company was founded in 2017 and is based in Camberwell, Australia.
Stocks similar to Island Pharmaceuticals
Island Pharmaceuticals in the news
Frequently asked questions
More guides on Finder
How to buy BITO ETF units | $43.28
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Why is the AMP share price looking up today?
Shares in the wealth management giant have been largely stable in the last 6 months.
How to invest in the Judo Capital Holdings IPO
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
How to invest in the Allaggio Group IPO
Everything we know about the Allaggio Group IPO, plus information on how to buy in.
How to invest in the Larvotto Resources IPO
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
How to invest in the Vulcan Steel IPO
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
How to invest in the Artrya IPO
Everything we know about the Artrya IPO, plus information on how to buy in.
How to invest in the 8 Au IPO
Everything we know about the 8 Au IPO, plus information on how to buy in.
How to invest in the Radiopharm Theranostics IPO
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
What has prompted the rebound in the Kogan share price?
The online retailer’s shares have lost more than half their value in the last 12 months.
Ask an Expert